Topics covered: Risk Of W-Shaped Recovery, Return Of M&A Activity In 2011, Overall Sector Uncertainty, Outlook For Credit Legislation & Consumer Oversight, Optimism In Tracking Commercial Real Estate, Industrywide Lower ROE & Leverage, Increased Regulatory Pressure, Impact Of Overdraft Fee Restrictions, Emphasis On FDIC-Assisted Transactions, Adequate Access To Capital
Companies covered: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), United Therapeutics Corporation (NASDAQ:UTHR), Ardea Biosciences, Inc., Pozen, Inc. (NASDAQ:POZN), Pfizer, Inc. (NYSE:PFE), Nektar Therapeutics (NASDAQ:NKTR), Merck & Company, Inc. (NYSE:MRK), Medivation, Inc. (NASDAQ:MDVN), Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), GlaxoSmithKline PLC (NYSE:GSK), Dendreon Corp., AstraZeneca PLC (NASDAQ:AZN), Auxilium Pharmaceuticals Inc., Depomed, Inc. (NASDAQ:DEPO), Schiff Nutrition International, Citizens Republic Bancorp, Inc, Home Bancorp, Inc. (NASDAQ:HBCP), Eastern Virginia Bankshares, Inc. (NASDAQ:EVBS), Integra Bank Corp., German American Bancorp, Inc. (NASDAQ:GABC), Target Corporation (NYSE:TGT), Staples, Inc. (NASDAQ:SPLS), Saks Incorporated, Ralph Lauren Corporation (NYSE:RL), OfficeMax Inc., Office Depot, Inc. (NASDAQ:ODP), Kohl's Corporation (NYSE:KSS), J.C. Penney Company, Inc. (OTCMKTS:JCPNQ), Zions Bancorporation (NASDAQ:ZION), Wintrust Financial Corporation (NASDAQ:WTFC), MB Financial Inc. (NASDAQ:MBFI), J P Morgan Chase & Co (NYSE:JPM), IBERIABANK Corporation (NASDAQ:IBKC), FirstMerit Corporation (NASDAQ:FMER), Bank of America Corporation (NYSE:BAC), American International Group, Inc. (NYSE:AIG)
